Ziming Li

机构：Shanghai Jiao Tong University, Shanghai Chest Hospital, First Affiliated Hospital of Guangzhou Medical University, 82th Hospital of Pla, Guangzhou Medical University · ORCID：0009-0005-5718-2145

发表论文 127 篇 · 总被引 2360 次 · h-index 26

代表论文

• Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432) (2024 · Signal Transduction and Targeted Therapy · 被引 18)
• Comparative efficacy and safety of first‑line PD‑1/PD‑L1 inhibitors in immunotherapy for non‑small cell lung cancer: A network meta‑analysis (2025 · Oncology Letters · 被引 6)
• Development of Reliable Male-Specific Molecular Markers for Genetic Sex Identification in Sea Cucumber Apostichopus japonicus (2024 · Marine Biotechnology · 被引 6)
• Enzyme-armed nanocleaner provides superior detoxification against organophosphorus compounds via a dual-action mechanism (2024 · Journal of Nanobiotechnology · 被引 5)
• New Drug Approvals in China: An International Comparative Analysis, 2019-2023 (2025 · Drug Design Development and Therapy · 被引 4)
• NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer (2025 · Biomarker Research · 被引 4)